Risk of MS relapse after yellow fever vaccination: A self-controlled case series

Csaki Huttner, Angela; Eperon, Gilles Alain; Lascano, Agustina Maria; Roth, Serge; Schwob, Jean-Marc; Siegrist, Claire-Anne; Lalive d'Epinay, Patrice

doi:10.1212/NXI.0000000000000726

Scientific article

English

Risk of MS relapse after yellow fever vaccination: A self-controlled case series

ContributorsCsaki Huttner, Angela; Eperon, Gilles Alain; Lascano, Agustina Maria

; Roth, Serge; Schwob, Jean-Marc; Siegrist, Claire-Anne; Lalive d'Epinay, Patrice

Published inNeurology: Neuroimmunology & Neuroinflammation, vol. 7, no. 4, e726

Publication date2020

Abstract

To determine whether live-attenuated yellow fever vaccine (YFV) was associated with MS relapse, we evaluated the clinical courses of 23 patients in the year before and the year after immunization at the university hospital of Geneva, Switzerland.

Affiliation entities

Research groups

Citation (ISO format)

CSAKI HUTTNER, Angela et al. Risk of MS relapse after yellow fever vaccination: A self-controlled case series. In: Neurology: Neuroimmunology & Neuroinflammation, 2020, vol. 7, n° 4, p. e726. doi: 10.1212/NXI.0000000000000726

Article (Published version)

CC BY-NC-ND

Identifiers

PID : unige:153687
DOI : 10.1212/NXI.0000000000000726
PMID : 32358223

Additional URL for this publicationhttps://nn.neurology.org/content/7/4/e726

Journal ISSN2332-7812

251views

98downloads

Creation07/16/2021 3:04:00 PM

First validation07/16/2021 3:04:00 PM

Update time03/16/2023 12:59:28 AM

Status update03/16/2023 12:59:27 AM

Last indexation02/09/2025 3:48:46 PM

Archive ouverte UNIGE

Risk of MS relapse after yellow fever vaccination: A self-controlled case series

To determine whether live-attenuated yellow fever vaccine (YFV) was associated with MS relapse, we evaluated the clinical courses of 23 patients in the year before and the year after immunization at the university hospital of Geneva, Switzerland.

Technical informations